Stay updated with breaking news from John Savin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Proactive Healthcare Analyst Dr John Savin joined Steve Darling to delved into the recent strategic developments at NanoViricides (NYSE-A:NNVC), shedding...
Proactive research analyst John Savin speaks to Stephen Gunnion after publishing a research note about the latest Covid trial from development-stage...
Proactive research analyst John Savin speaks to Thomas Warner after publishing a new research note on pharmaceutical group Oxford Cannabinoid Technologies...
Proactive research analyst John Savin speaks to Thomas Warne after publishing a research note about the latest Covid trial from development-stage antiviral...
Proactive research analyst John Savin speaks to Thomas Warner after releasing a new report on NanoViricides (NYSE-A:NNVC), a development-stage company that...